MICRO-X LIMITED — Director's Dealing 2018

Jan 23, 2018

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Micro-X Ltd ABN 21 153 273 735

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Richard Hannebery
Date of last notice	3 October 2017

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest		Direct and Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.		Domain Capital Biotech Investments Pty Limited (Mr Hannebery is a director of this entity and is a beneficiary) Mrs Robyn Gould (spouse of Mr Hannebery) Silica Investments Pty Limited (Mr Hannebery is a beneficiary of this entity)
Date of change		18 January 2018
No. of securities held prior to change		Direct 696,556 Unlisted Options exercisable at $0.575 (57.5 cents) on or before 31/12/19 1,393,114 Unlisted Options exercisable at $0.625 (62.5 cents) on or before 31/12/19 262,500 Ordinary Fully Paid Shares Indirect 3,093,450 OrdinaryFullyPaid Shares

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class		Fully Paid Ordinary Shares
Number acquired
Number disposed		349,600
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		Nil – Distribution from Trust
No. of securities held after change		Direct 696,556 Unlisted Options exercisable at $0.575 (57.5 cents) on or before 31/12/19 1,393,114 Unlisted Options exercisable at $0.625 (62.5 cents) on or before 31/12/19 262,500 Ordinary Fully Paid Shares Indirect 2,743,850 Ordinary Fully Paid Shares
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back		Off market transfer - Distribution of Ordinary Shares from Domain Capital Biotech Investments held on Trust

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	Indirect
Name of registered holder (if issued securities)	Domain Capital Biotech Investments Pty Limited
Date of change	18 January 2018
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	349,600
Interest acquired	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest disposed	349,600
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	Nil – Distribution from Trust
Interest after change	349,600

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3